Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices

Patients With Prolonged Intravenous Therapy Clinical Trial

— ETI  

Official title:

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01548365
• Other study ID #: ITNE01
• Status: Completed
• Phase: N/A
• First received: March 5, 2012
• Last updated: September 20, 2013
• Start date: March 2012
• Est. completion date: December 2012

Study information

• Verified date: September 2013
• Source: Basque Health Service
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 82
• Est. completion date: December 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy.

• Estimation of 7 days or more of continuous intravenous therapy.

• Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months.

• Be patient at Araba University Hospital

Exclusion Criteria:

• To have a central venous catheter indwelled

• MRSA (Methicillin Resistant Staphylococcus Aureus)

• Younger than 18 years old

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Patients With Prolonged Intravenous Therapy

Intervention

Other:
• Infusion therapy nursing expert service
The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Locations

Country	Name	City	State
Spain	Araba University Hospital	Vitoria-Gasteiz	Araba

Sponsors (2)

Lead Sponsor	Collaborator
Basque Health Service	KRONIKGUNE Cronicity Research Centre

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Length of Stay		3 months	Yes
Secondary	Venous Access Devices reaching end of treatment		3 months	Yes
Secondary	Incidence of complications derived from VAD		3 months	Yes
Secondary	Patients receiving intravenous therapy at home		3 months	Yes
Secondary	Patient satisfaction with VAD		3 months	No